Press Releases on February 28, 2023 - EIN Presswire - Press Release Distribution Service

Published on February 28, 2023 - 21:05 GMT

Alector Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update

On track to complete enrollment in the INVOKE-2 Phase 2 clinical trial of AL002 in patients with early Alzheimer’s disease in Q3 2023, with data readout expected by Q4 2024 Preparing to engage with regulatory authorities in mid-2023 and targeting data …

Distribution channels: Business & Economy ...

Published on February 28, 2023 - 21:05 GMT

Atea Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update

Phase 3 SUNRISE-3 trial evaluating bemnifosbuvir for treatment of COVID-19 in high-risk patients continues enrollment; interim analysis expected in 2H23 Phase 2 trial evaluating combination of bemnifosbuvir and ruzasvir for treatment of HCV to start …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...

Published on February 28, 2023 - 21:05 GMT

Myriad Genetics Reports Fourth Quarter Financial Results; Fourth Quarter Revenue of $177.8 Million Grew 11% Year-Over-Year Driven ...

Highlights: Fourth quarter testing volumes grew 26% year-over-year, and 11% year-over-year excluding the contribution from the recent acquisition of Gateway Genomics and its SneakPeek® Early Gender DNA Test. GeneSight, the company's pharmacogenomics …

Distribution channels: Business & Economy, Technology ...

Published on February 28, 2023 - 21:05 GMT

Jamf Announces Fourth Quarter and Fiscal Year 2022 Financial Results

Q4 total revenue year-over-year growth of 26% to $130.3 million; fiscal year total revenue growth of 31% to $478.8 million ARR year-over-year growth of 24% to $512.5 million as of December 31, 2022 Cash flow provided by operations of $90.0 million for the …

Distribution channels: Business & Economy, Technology ...

Published on February 28, 2023 - 21:05 GMT

URBN Reports Q4 Results

PHILADELPHIA, Feb. 28, 2023 (GLOBE NEWSWIRE) -- Urban Outfitters, Inc. (NASDAQ:URBN), a leading lifestyle products and services company which operates a portfolio of global consumer brands comprised of the Anthropologie, BHLDN, Free People, FP Movement, …

Distribution channels: Business & Economy, Textiles & Fabric Industry ...

Published on February 28, 2023 - 21:05 GMT

Corcept Therapeutics Announces Fourth Quarter and Full-Year 2022 Audited Financial Results and Provides Corporate Update

MENLO PARK, Calif., Feb. 28, 2023 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrine, oncologic, metabolic and neurological …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...

Published on February 28, 2023 - 21:05 GMT

OrthoPediatrics Corp. Reports Fourth Quarter and Full Year 2022 Financial Results

Fourth Quarter 2022 Revenue Increased 25% Year-over-Year Full Year 2022 Revenue Increased 25% Year-over-Year WARSAW, Ind., Feb. 28, 2023 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...

Published on February 28, 2023 - 21:05 GMT

Silk Road Medical Reports Fourth Quarter and Full Year 2022 Financial Results and Provides 2023 Financial Outlook

SUNNYVALE, Calif., Feb. 28, 2023 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today reported financial results for the three months and full year ended December 31, …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...

Published on February 28, 2023 - 21:05 GMT

Chimerix to Present at Cowen and Company 43rd Annual Health Care Conference

DURHAM, N.C., Feb. 28, 2023 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), a biopharmaceutical company whose mission is to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases, today announced that Mike Sherman, …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...

Published on February 28, 2023 - 21:05 GMT

Aligos Therapeutics to Announce Fourth Quarter Results March 9, 2023

SOUTH SAN FRANCISCO, Calif., Feb. 28, 2023 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”, the “Company”), a clinical stage biopharmaceutical company focused on developing novel therapeutics to address unmet medical needs in …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...

Published on February 28, 2023 - 21:05 GMT

Aravive Announces FDA Orphan Drug Designation Granted to Batiraxcept for the Treatment of Pancreatic Cancer

Dose escalation portion of ongoing Phase 1b/2 pancreatic adenocarcinoma trial initiated, with preliminary results expected in 2H 2023 HOUSTON, Feb. 28, 2023 (GLOBE NEWSWIRE) -- Aravive, Inc. (Nasdaq: ARAV, “the Company”), a late clinical-stage oncology …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on February 28, 2023 - 21:05 GMT

Proterra CEO Gareth Joyce Appointed by President Biden to the President’s Export Council

BURLINGAME, Calif., Feb. 28, 2023 (GLOBE NEWSWIRE) -- Proterra Inc (NASDAQ: PTRA), a leading innovator in commercial vehicle electrification technology, today announced that Chief Executive Officer Gareth Joyce has been appointed by President Biden to …

Distribution channels:

Published on February 28, 2023 - 21:05 GMT

Flywire Reports Fourth Quarter and Fiscal-Year 2022 Financial Results

Fourth Quarter Revenue Increased 42% Year-over-Year Fourth Quarter Revenue Less Ancillary Services Increased 47% Year-over-Year Fourth Quarter Revenue Less Ancillary Services at Constant Currency Increased 57% Year-Over-Year Fourth Quarter Gross Profit …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...

Published on February 28, 2023 - 21:03 GMT

Governor Abbott Announces Music Friendly Texas Community Workshop In College Station

February 28, 2023 | Austin, Texas | Press Release Governor Greg Abbott today announced the Texas Music Office (TMO), the City of College Station, and Visit College Station will co-host a Music Friendly Texas Community workshop on Tuesday, March 7. “Music …

Distribution channels:

Published on February 28, 2023 - 21:03 GMT

PROCEPT BioRobotics Reports Fourth Quarter and Full Year 2022 Results

REDWOOD CITY, Calif., Feb. 28, 2023 (GLOBE NEWSWIRE) -- PROCEPT® BioRobotics Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today reported …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...

Published on February 28, 2023 - 21:03 GMT

Health Catalyst Reports Fourth Quarter and Year End 2022 Results

SOUTH JORDAN, Utah, Feb. 28, 2023 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today reported financial results for the …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...

Published on February 28, 2023 - 21:03 GMT

Franchise Group, Inc. Announces Approval of Quarterly Preferred Dividend

DELAWARE, Ohio, Feb. 28, 2023 (GLOBE NEWSWIRE) -- Franchise Group, Inc. (NASDAQ: FRG) (“Franchise Group” or the “Company”) today announced that its Board of Directors approved a quarterly dividend of $0.46875 per share to Series A Cumulative Perpetual …

Distribution channels: Banking, Finance & Investment Industry ...

Published on February 28, 2023 - 21:02 GMT

iSpecimen to Report Fourth Quarter and Full Year 2022 Results on March 14, 2023

LEXINGTON, Mass., Feb. 28, 2023 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists in need of biospecimens for medical research with a network of healthcare specimen …

Distribution channels: Culture, Society & Lifestyle, Technology ...

Published on February 28, 2023 - 21:02 GMT

SLR Investment Corp. Announces Quarter and Fiscal Year Ended December 31, 2022 Financial Results

Net Investment Income of $0.41 Per Share for Q4 2022 Distributions of $0.41 Per Share for Q1 2023 NEW YORK , Feb. 28, 2023 (GLOBE NEWSWIRE) -- SLR Investment Corp. (NASDAQ: SLRC) (the “Company” or “SLRC”) today reported net investment income of $22.5 …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...

Published on February 28, 2023 - 21:02 GMT

Allogene Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update

Initiated Industry’s First Potentially Pivotal Phase 2 Allogeneic CAR T Trial, ALPHA2, in Relapsed/Refractory (R/R) Large B Cell Lymphoma (LBCL) Presented Data Highlighting Industry-Leading Allogeneic CAR T Portfolio CD19 (ALLO-501/A): Six Month Durability …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...